191 related articles for article (PubMed ID: 37986052)
1. Enhancing the clinical diagnosis of the acute and subacute phases of autoimmune encephalitis and predicting the risk factors: the potential advantages of 18F-FDG PET/CT.
Liu L; Lyu Z; Li H; Bai L; Wan Y; Li P
BMC Med Imaging; 2023 Nov; 23(1):193. PubMed ID: 37986052
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of brain FDG PET/CT imaging in pediatric patients with suspected autoimmune encephalitis from a prospective study.
Yin Y; Wu J; Wu S; Chen S; Cheng W; Li L; Wang H
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1918-1929. PubMed ID: 34939173
[TBL] [Abstract][Full Text] [Related]
4. A novel classification model based on cerebral 18F-FDG uptake pattern facilitates the diagnosis of acute/subacute seropositive autoimmune encephalitis.
Bai S; Zhang C; Yao X; Shao H; Huang G; Liu J; Hao Y; Guan Y
J Neuroradiol; 2023 Sep; 50(5):492-501. PubMed ID: 37142216
[TBL] [Abstract][Full Text] [Related]
5. Typical metabolic pattern of
Yuan L; Mao G; Zhang Y; Xu Y; Chen Q; Shan B; Cui T; Ai L
BMC Neurosci; 2023 Sep; 24(1):51. PubMed ID: 37749547
[TBL] [Abstract][Full Text] [Related]
6. Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report.
Namura K; Minamimoto R; Yao M; Makiyama K; Murakami T; Sano F; Hayashi N; Tateishi U; Ishigaki H; Kishida T; Miura T; Kobayashi K; Noguchi S; Inoue T; Kubota Y; Nakaigawa N
BMC Cancer; 2010 Dec; 10():667. PubMed ID: 21129184
[TBL] [Abstract][Full Text] [Related]
7. 18F-Flurodeoxyglucose positron emission tomography with computed tomography (FDG PET/CT) findings in children with encephalitis and comparison to conventional imaging.
Turpin S; Martineau P; Levasseur MA; Meijer I; Décarie JC; Barsalou J; Renaud C; Decaluwe H; Haddad E; Lambert R
Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1309-1324. PubMed ID: 30863933
[TBL] [Abstract][Full Text] [Related]
8. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
9. Comparison of brain F-18 FDG PET/MRI with PET/CT imaging in pediatric patients.
Sager G; Akgun E; Abuqbeitah M; Uslu L; Asa S; Akgun MY; Beytur F; Baydili KN; Sager S
Clin Neurol Neurosurg; 2021 Jul; 206():106669. PubMed ID: 33984753
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of
Solnes LB; Jones KM; Rowe SP; Pattanayak P; Nalluri A; Venkatesan A; Probasco JC; Javadi MS
J Nucl Med; 2017 Aug; 58(8):1307-1313. PubMed ID: 28209905
[TBL] [Abstract][Full Text] [Related]
11. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA
Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
[TBL] [Abstract][Full Text] [Related]
12.
Liu X; Yu T; Zhao X; Li G; Lv R; Ai L; Wang Q
CNS Neurosci Ther; 2022 Feb; 28(2):269-278. PubMed ID: 34837479
[TBL] [Abstract][Full Text] [Related]
13. Role of FDG PET/CT in definitive and presumed autoimmune encephalitis.
Kalra S; Tripathi M; Tripathi M; Sonar RS; Pandey AK; Jaleel J; Singh RK; Kumar P; Damle NA; Bal C
Nucl Med Commun; 2024 Feb; 45(2):121-127. PubMed ID: 37982572
[TBL] [Abstract][Full Text] [Related]
14. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
15. [18F]FDG brain PET and clinical symptoms in different autoantibodies of autoimmune encephalitis: a systematic review.
Nabizadeh F; Ramezannezhad E; Sardaripour A; Seyedi SA; Salehi N; Rezaeimanesh N; Naser Moghadasi A
Neurol Sci; 2022 Aug; 43(8):4701-4718. PubMed ID: 35486333
[TBL] [Abstract][Full Text] [Related]
16. Comparison of quantitative FDG-PET and MRI in anti-LGI1 autoimmune encephalitis.
Sadaghiani MS; Roman S; Diaz-Arias LA; Habis R; Venkatesan A; Probasco JC; Solnes LB
Neuroradiology; 2023 Aug; 65(8):1225-1238. PubMed ID: 37264220
[TBL] [Abstract][Full Text] [Related]
17. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E
Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of decreased uptake of 18F-fluorodeoxyglucose in the cerebral cortex of patients with intracranial non-Hodgkin's lymphoma lesions through PET/CT.
Zhang Q; Tian T; Wang L; Qiu H; Li D
Biomed Pharmacother; 2016 Dec; 84():1331-1336. PubMed ID: 27810790
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET/CT findings in endometrial cancer patients: the correlation between SUVmax and clinicopathologic features.
Boonya-ussadorn T; Choi WH; Hyun J; Kim SH; Chung SK; Yoo IeR
J Med Assoc Thai; 2014 Feb; 97 Suppl 2():S115-22. PubMed ID: 25518184
[TBL] [Abstract][Full Text] [Related]
20. Standardized uptake value of normal organs on routine clinical [18F]FDG PET/CT: impact of tumor metabolism and patient-related factors.
Sharma P; Chatterjee P; Alvarado LA; Dwivedi AK
Nucl Med Rev Cent East Eur; 2023; 26(0):1-10. PubMed ID: 36286203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
